Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-11786487-B2 United States of America 17 Oct 2023
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-11759440-B2 United States of America 19 Sep 2023
Metabolism resistant fenfluramine analogs and methods of using the same Grant US-11673852-B2 United States of America 13 Jun 2023
Fenfluramine compositions and methods of preparing the same Grant US-11634377-B2 United States of America 25 Apr 2023
Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 … Grant US-11612574-B2 United States of America 28 Mar 2023
Compositions and methods for treating seizure-induced sudden death Grant US-11571397-B2 United States of America 07 Feb 2023
Ketogenic diet compatible fenfluramine formulation Grant US-11458111-B2 United States of America 04 Oct 2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-11406606-B2 United States of America 09 Aug 2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-11040018-B2 United States of America 22 Jun 2021
Compositions and methods for treating respiratory depression with fenfluramine Grant US-10952976-B2 United States of America 23 Mar 2021
Ketogenic diet compatible fenfluramine formulation Grant US-10682317-B2 United States of America 16 Jun 2020
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-10603290-B2 United States of America 31 Mar 2020
Compositions and methods for treating respiratory depression with fenfluramine Grant US-10517841-B1 United States of America 31 Dec 2019
Method for the treatment of Dravet Syndrome Grant US-10478442-B2 United States of America 19 Nov 2019
Method for the treatment of Dravet syndrome Grant US-10478441-B2 United States of America 19 Nov 2019